Investor · Southington, CT

Mark L. Ricciardelli

Open Mark in the network graph →

Filings

11

SEC Form D

Connections

24

co-filers

Capital

$550K

across filings

Active

Feb 2012

to Mar 2017

Most-connected co-filers (24)

Andreas P. Graham · Corona Del Mar, CA10 shared Jay Moorin · Tyler, TX6 shared Christopher T. Miller · Lakewood, CO6 shared Jack H. Brier · Topeka, KS6 shared Martin Vogelbaum · New York, NY6 shared Alan Colowick · San Diego, CA6 shared Curtis Feeny · BERKELEY, CA6 shared Seth Harrison · New York, NY6 shared Jean C. Nichols · Cambridge, MA6 shared Nicholas Vrolijk · Cambridge, MA6 shared David Schnell · Cambridge, MA6 shared Donald J. Hayden · Cambridge, MA6 shared David Hanna · Sunnyvale, CA6 shared William Gurley · Sunnyvale, CA6 shared Mason L. Kuehl · Denton, TX6 shared Glenn L. Halpryn · Irvine, CA4 shared Casper W. Zublin · Corona Del Mar, CA4 shared Henry Beinstein · Mount Kisco, NY4 shared Harvey Eisen · Rochester, NY3 shared Thomas Dyrberg · Bernardsville, NJ1 shared Timothy W. Kristof · Middletown, CT1 shared James L. Mooney · Southington, CT1 shared Mark L. Steenberg · Southington, CT1 shared Robert Conerly · Southington, CT1 shared

Recent filings (11)

Mr. Bully Holdings, Inc.Mar 2017 · 7 co-filers$612K Mr. Bully Holdings, Inc.Mar 2017 · 7 co-filers$612K Asterisk Financial Group, Inc.Feb 2012 · 6 co-filers$3.0M Asterisk Financial Group, Inc.Feb 2012 · 6 co-filers$3.0M Asterisk Financial Group, Inc.May 2010 · 5 co-filers$8.0M U.S. Risk Partners Holdings, Inc.May 2010 · 5 co-filers$8.0M Gloucester Pharmaceuticals IncAug 2009 · 17 co-filers$28.9M Gloucester Pharmaceuticals IncAug 2009 · 15 co-filers$500K Gloucester Pharmaceuticals IncJul 2009 · 15 co-filers$500K Gloucester Pharmaceuticals IncJun 2009 · 15 co-filers$1.5M U.S. Risk Partners Holdings, Inc.May 2009 · 5 co-filers$1.5M Gloucester Pharmaceuticals IncMay 2009 · 15 co-filers$1.7M Gloucester Pharmaceuticals IncApr 2009 · 15 co-filers$1.5M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Mark in the interactive graph →